Post-finasteride Syndrome Foundation is a 501(c)(3) organization based in Somerset, New Jersey, registered in 2013, with $91,449 in FY2024 revenue. CharityIndex grades it B.
Revenue (FY2024)
$91K
▲ 34.7% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$76K
Net assets
$32K
Employees
—
Rated on 2 of 4 criteria — the rest aren't reported in this filing type.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for Post-finasteride Syndrome Foundation— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Post-finasteride Syndrome Foundation: 5 mo reserves · +17% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for Post-finasteride Syndrome Foundation— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Post-finasteride Syndrome Foundation: 2 of 5 disclosure signals earns a C on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue declined from $492K (FY2013) to $91K (FY2024) across 12 reported years.
Financial snapshot
Operating margin
16.8%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$32K
Total liabilities
$0
Net assets
$32K
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $91,449▲34.7% | $76,091▼10.1% | $32,318▲90.6% | $32,318▲90.6% | 990 |
| 2023 | $67,901▲36.3% | $84,663▲104% | $16,960▼49.7% | $16,960▼49.7% | 990 |
| 2022 | $49,812▲244% | $41,418▼25.8% | $33,722▲33.1% | $33,722▲33.1% | 990 |
| 2021 | $14,476▼83.4% | $55,855▲39.1% | $25,328▼81.3% | $25,328▼81.3% | 990 |
| 2020 | $87,153▲150% | $40,158▼46.2% | $135,332▲53.2% | $135,332▲53.2% | 990 |
| 2019 | $34,917▼82.4% | $74,642▼55.9% | $88,337▼31.0% | $88,337▼31.0% | 990 |
| 2018 | $198,794▲141% | $169,227▲92.0% | $128,062▲30.0% | $128,062▲30.0% | 990 |
| 2017 | $82,559▼46.9% | $88,138▼28.7% | $98,495▼5.4% | $98,495▼5.4% | 990 |
| 2016 | $155,509▲379% | $123,539▲15.6% | $104,074▲44.3% | $104,074▲44.3% | 990 |
| 2015 | $32,468▼91.6% | $106,845▼56.9% | $72,104▼50.8% | $72,104▼50.8% | 990 |
| 2014 | $384,600▼21.9% | $248,021▼49.3% | $146,481▲1379% | $146,481▲145% | 990 |
| 2013 | $492,158 | $489,620 | $9,902 | $59,902 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Explore more
Data for Post-finasteride Syndrome Foundation (EIN 46-0573960) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.